Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.

Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, Diller LR, Stovall M, Donaldson SS, Robison LL.

Pediatr Blood Cancer. 2014 Jan;61(1):53-67. doi: 10.1002/pbc.24679. Epub 2013 Aug 12.

2.

Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA, Chemaitilly W, Pui CH, Klosky JL, Spunt SL, Metzger ML, Srivastava D, Ness KK, Robison LL, Hudson MM.

Lancet Oncol. 2014 Oct;15(11):1215-23. doi: 10.1016/S1470-2045(14)70408-5. Epub 2014 Sep 16.

3.

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study.

Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL.

J Natl Cancer Inst. 2006 Jul 5;98(13):890-6.

PMID:
16818852
4.

Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature.

Thomas-Teinturier C, El Fayech C, Oberlin O, Pacquement H, Haddy N, Labbé M, Veres C, Guibout C, Diallo I, De Vathaire F.

Hum Reprod. 2013 Feb;28(2):488-95. doi: 10.1093/humrep/des391. Epub 2012 Nov 15.

PMID:
23154067
5.

Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.

Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL.

J Clin Oncol. 2009 Jun 1;27(16):2677-85. doi: 10.1200/JCO.2008.20.1541. Epub 2009 Apr 13.

6.

Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.

Chow EJ, Stratton KL, Leisenring WM, Oeffinger KC, Sklar CA, Donaldson SS, Ginsberg JP, Kenney LB, Levine JM, Robison LL, Shnorhavorian M, Stovall M, Armstrong GT, Green DM.

Lancet Oncol. 2016 May;17(5):567-76. doi: 10.1016/S1470-2045(16)00086-3. Epub 2016 Mar 22.

7.

Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort.

Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L.

Lancet Oncol. 2013 Aug;14(9):873-81. doi: 10.1016/S1470-2045(13)70251-1. Epub 2013 Jul 13.

8.

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group.

Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.

PMID:
26271204
9.

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study.

Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y.

J Clin Oncol. 2009 May 10;27(14):2374-81. doi: 10.1200/JCO.2008.21.1839. Epub 2009 Apr 13. Review.

10.

Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.

Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, Klosky JL, Barnes N, Clark KL, Farr JB, Fernandez-Pineda I, Bishop MW, Metzger M, Pui CH, Kaste SC, Ness KK, Srivastava DK, Robison LL, Hudson MM, Yasui Y, Sklar CA.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2242-2250. doi: 10.1210/jc.2016-3723.

PMID:
28368472
11.
12.

Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL.

J Clin Oncol. 2010 Jan 10;28(2):332-9. doi: 10.1200/JCO.2009.24.9037. Epub 2009 Nov 30.

13.

Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.

Fleming RA, Cruz JM, Webb CD, Kucera GL, Perry JJ, Hurd DD.

Bone Marrow Transplant. 1996 Apr;17(4):497-501.

PMID:
8722345
14.

Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, Pendergrass TW, Robison LL.

Am J Obstet Gynecol. 2002 Oct;187(4):1070-80.

PMID:
12389007
15.

ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.

Harper P.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-23-S15-25.

PMID:
9346217
16.

Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, Sklar CA.

Pediatr Blood Cancer. 2008 Apr;50(4):854-8.

PMID:
17729247
17.

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr, Gilbert E.

JAMA. 2003 Jul 23;290(4):465-75. Erratum in: JAMA. 2003 Sep 10;290(10):1318.

PMID:
12876089
18.

Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.

Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, Sklar CA, Donaldson SS, Anderson H, Bhatti P, Hammond S, Leisenring WM, Mertens AC, Smith SA, Stovall M, Tucker MA, Weathers RE, Robison LL, Pfeiffer RM.

J Clin Oncol. 2013 Jan 1;31(1):119-27. doi: 10.1200/JCO.2012.41.8996. Epub 2012 Nov 19. Erratum in: J Clin Oncol. 2013 Feb 20;31(6):824.

19.

Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, Stovall MA.

J Natl Cancer Inst. 1996 Mar 6;88(5):270-8.

PMID:
8614005
20.

Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.

Ridola V, Fawaz O, Aubier F, Bergeron C, de Vathaire F, Pichon F, Orbach D, Gentet JC, Schmitt C, Dufour C, Oberlin O.

Eur J Cancer. 2009 Mar;45(5):814-8. doi: 10.1016/j.ejca.2009.01.002. Epub 2009 Feb 11.

PMID:
19216070

Supplemental Content

Support Center